Connect with your Bayer Representative with any questions

IMPORTANT SAFETY INFORMATION:
You should not use KOVALTRY^® if you are allergic to rodents (like mice and hamsters) or any ingredients in KOVALTRY^®. Continue reading below

Welcome, {NAME}—
We're looking forward to connecting you with people, resources, and support that can help with the management of hemophilia A. Don't hesitate to reach out to your rep with any questions, or to learn more about what we have to offer.

	Meet {REPNAME}, your local Bayer Representative
	Your source for experienced assistance and support. Get to know your personal connection at Bayer today! Connect with your rep >

	Questions about insurance or financial support?
	Bayer Access Solutions is here to help you through coverage challenges and to provide expert assistance through our live helpline. See what we can do. Connect with Bayer Access Solutions >

INDICATIONS

•	KOVALTRY^® is a medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A.

•	KOVALTRY^® is used to treat and control bleeding in adults and children with hemophilia A. KOVALTRY^® can reduce the number of bleeding episodes in adults and children with hemophilia A when used regularly (prophylaxis). Your healthcare provider may give you KOVALTRY^® when you have surgery.

•	KOVALTRY^® is not used to treat von Willebrand Disease.

IMPORTANT SAFETY INFORMATION

•	You should not use KOVALTRY^® if you are allergic to rodents (like mice and hamsters) or any ingredients in KOVALTRY^®.

•	Tell your healthcare provider if you have heart disease or are at risk for heart disease.

•	The common side effects of KOVALTRY^® are headache, fever, and itchy rash.

•	Allergic reactions may occur with KOVALTRY^®. Call your healthcare provider right away and stop treatment if you get tightness of the chest or throat, dizziness, decrease in blood pressure, and nausea.

•	Your body can also make antibodies, called "inhibitors," against KOVALTRY^®, which may stop KOVALTRY^® from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for the development of inhibitors to Factor VIII.

•	Tell your healthcare provider about any side effect that bothers you or that does not go away.

•	Call your healthcare provider right away if bleeding is not controlled after using KOVALTRY^®.

For additional important risk and use information, click here for full Prescribing Information.

You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

Please note: this e-mail is not monitored for replies. If you would like to contact us, please visit our Contact Us section online.

1‌00 B‌ayer B‌oulevard, P‌O B‌ox 9‌15, W‌hippany, N‌J 0‌7981-0‌915 U‌SA

Unsubscribe